United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 1,288,500 | 1,116,984 | 916,076 | 743,183 | 592,899 |
| Cost of Goods | 125,900 | 131,127 | 119,297 | 88,904 | 67,674 |
| Gross Profit | 1,162,600 | 985,857 | 796,779 | 654,279 | 525,225 |
| Operating Expenses | 624,700 | 693,485 | 375,430 | 337,401 | 354,586 |
| Operating Income | 538,800 | 292,499 | 421,646 | 317,782 | 171,313 |
| Interest Expense | 17,600 | 18,058 | 16,639 | 21,367 | 19,710 |
| Other Income | 4,000 | 4,462 | 35,664 | 2,702 | 3,548 |
| Pre-tax Income | 525,200 | 278,903 | 440,671 | 299,117 | 155,151 |
| Income Tax | 185,100 | 104,343 | 136,229 | 81,874 | 43,945 |
| Net Income Continuous | 340,100 | 174,560 | 304,442 | 217,243 | 111,206 |
| Net Income Discontinuous | N/A | N/A | N/A | 625 | -5,290 |
| Net Income | $340,100 | $174,560 | $304,442 | $217,868 | $105,916 |
| EPS Basic Total Ops | 7.06 | 3.49 | 5.84 | 3.81 | 1.89 |
| EPS Basic Continuous Ops | 7.06 | 3.49 | 5.84 | 3.80 | 1.98 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.01 | -0.09 |
| EPS Diluted Total Ops | 6.28 | 3.28 | 5.71 | 3.67 | 1.78 |
| EPS Diluted Continuous Ops | 6.27 | 3.28 | 5.71 | 3.66 | 1.87 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.01 | -0.09 |
| EBITDA(a) | $571,000 | $340,860 | $464,459 | $362,150 | $208,646 |